TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
INCY

Incyte Corporation

Healthcare · Biotechnology

123.90$ -0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow INCY
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.1% 11.5% 27.6% -6.1% 17.9% 32.9% -4.7% 25.1% 28.6% 13.4% 7.9% 27.5%
8.1% 6.0% 5.3% 3.4% 2.9% 2.5% 1.9% 1.9% 2.0% 2.2% 2.1% 1.8%
12.2% 9.3% 8.7% 8.7% 7.9% 7.7% 6.7% 6.1% 5.6% 5.8% 6.3% 4.8%
12.2% 9.7% 10.6% 14.7% 9.3% 8.6% 7.6% -8.9% 8.1% – – –
-5.7% -4.6% 2.2% -4.2% -2.5% 2.7% -2.7% -0.5% 5.9% -6.7% 3.3% -10.3%
5.4% 3.4% 10.9% 7.2% 3.9% 3.6% 7.0% 6.1% 2.3% 1.3% 2.0% 1.1%
-27.1% -13.9% -21.0% -22.8% -4.6% -4.1% -10.1% -7.0% -2.3% -5.6% 3.7% -2.0%
0.0% 0.0% 0.0% 0.0% – 0.8% 0.9% 1.0% 0.8% – – –
18.2% 11.5% 4.5% 46.6% 1.6% -0.8% -0.9% -1.0% -0.8% -0.8% -47.3% -0.4%
0.0% -0.2% 1.2% 0.0% 0.0% 0.0% 0.0% -0.1% -0.1% -0.1% -0.1% -0.1%
18.2% 11.6% 5.3% 44.9% 0.8% 2.1% 2.7% 0.2% 0.0% -0.5% -47.7% 2.0%
-3.7% 9.2% 11.8% 16.1% 14.1% 31.0% -12.0% 18.2% 26.3% 7.1% -36.0% 27.4%
-0.3% 8.0% 16.7% -13.3% 14.0% 29.3% -11.7% 19.0% 26.3% 12.1% 5.9% 26.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?